HIV infection hijacks intracellular highways

September 27, 2017 by Will Doss, Northwestern University
Diaphanous-related formins promote trafficking of HIV particles (green) to the nucleus (blue). Credit: Northwestern University

A Northwestern Medicine study found the human immunodeficiency virus (HIV) uses proteins called diaphanous-related formins (DRFs) to hijack the cytoskeleton of healthy cells, findings that deepen the understanding of HIV infection and present a potential therapeutic target.

The paper was published in the Proceedings of the National Academy of Sciences and the lead author was Michael Delaney, PhD, a postdoctoral fellow in the lab of senior author Mojgan Naghavi, PhD, associate professor of Microbiology-Immunology.

The cytoskeleton, a network of interlinking filaments and tubules that gives structure to a cell and helps facilitate intracellular transport, has two important components—actin and microtubules. DRFs are involved in the regulation of both and HIV exploits discrete functions of DRFs to commandeer the functions of the cytoskeleton in a coordinated attack, according to the study.

"The virus has evolved to mimic these two regulatory functions of DRFs," said Naghavi, also a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Many viruses depend on microtubules to navigate through a cell, being too large to passively diffuse freely within the cytoplasmic environment. Instead, they require active transport to the nucleus where viral replication can begin.

"The virus exploits the regulatory function of DRFs, stabilizing the microtubules," Naghavi said. "Usually the microtubules are highly dynamic, but when they are stabilized, they can function as highways to transport the virus to the nucleus."

HIV also binds to DRF to regulate the disassembly of its capsid, a large protein shell that surrounds the HIV genome (a process also known as uncoating). While in uninfected cells DRFs have dual functions that coordinate actin and dynamics, HIV exploits these multifunctional DRFs to coordinate its uncoating with trafficking on stable microtubules to reach the nucleus, according to the study.

"Before we published this, it was unknown that they worked together," Naghavi said. "HIV is the only retrovirus we've tested so far that does this."

While previous studies had shown the somehow influenced microtubules, definitively identifying that pathway presents an opportunity for further study.

"Now, we are interested in factors up or downstream from DRFs," Naghavi said. "There are a handful of factors like DRFs that track microtubules, but nobody has looked at these factors and how they regulate viral infection."

Mapping the pathway would provide targets for intervention during early infection, according to Naghavi, but any treatment would have to tread lightly.

"The ultimate goal is being able to pinpoint the interaction between HIV and DRFs without affecting the normal of the DRFs," she said. "It's an area that's never been explored before."

Explore further: Novel approach to track HIV infection

More information: Michael Keegan Delaney et al. Distinct functions of diaphanous-related formins regulate HIV-1 uncoating and transport, Proceedings of the National Academy of Sciences (2017). DOI: 10.1073/pnas.1700247114

Related Stories

Novel approach to track HIV infection

August 18, 2017
Northwestern Medicine scientists have developed a novel method of tracking HIV infection, allowing the behavior of individual virions—infectious particles—to be connected to infectivity.

Recommended for you

Researchers identify source of molecule linked to nasal polyps, asthma attacks

May 23, 2018
A new discovery about how the immune system responds to common sinus infections and asthma could explain why patients develop these issues in the first place and ultimately may lead to improved targeted therapies. Researchers ...

Study demonstrates new treatment for severe asthma

May 22, 2018
Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph's Healthcare Hamilton, together with colleagues at other partnering institutions, have developed a new method to treat ...

Eczema drug effective against severe asthma

May 21, 2018
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies. Dupilumab, an injectable ...

Neuron guidance factor found to play a key role in immune cell function

May 21, 2018
Macrophages are white blood cells involved in a variety of biological functions, from destroying infectious pathogens to repairing damaged tissue. To carry out their different roles, macrophages must first be activated and ...

Immune cells hold promise in slowing down ALS

May 21, 2018
Recent research from Houston Methodist Hospital showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive ...

First clues to the causes of multiple sclerosis

May 16, 2018
Multiple sclerosis, which affects one in 1,000 people, is frequently characterised by relapses associated with variable functional impairments including among others vision problems, impairment of locomotor functions or difficulties ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.